Drug Discovery & Development - January 28, 2011
CANONSBURG, Pa. (AP) - Drugmaker Mylan Inc. said the Food and Drug Administration has approved four dose amounts of its generic version of Shionogi Pharma's Sular tablets for treating hypertension.
Mylan said the FDA approved 8.5-, 17-, 25.5- and 34-milligram doses of its Nisoldipine extended-release tablets. The company has been awarded six months of marketing exclusivity.
Date: January 28, 2011
Source: Associated Press
Mylan said the FDA approved 8.5-, 17-, 25.5- and 34-milligram doses of its Nisoldipine extended-release tablets. The company has been awarded six months of marketing exclusivity.
Date: January 28, 2011
Source: Associated Press
No hay comentarios:
Publicar un comentario